TENAX THERAPEUTICS, INC. Shareholders' Equity
TENAX THERAPEUTICS, INC. (TENX) had Shareholders' Equity of $113.59 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-07-31
- 2026-06-30: Stockholders' Equity Attributable to Parent $113.59M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $114.69M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $97.07M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $96.21M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $113.59M 10-Q · filed 2026-07-31 | |
| 2026-03-31 | $114.69M 10-Q · filed 2026-07-31 | |
| 2025-12-31 | $97.07M 10-Q · filed 2026-07-31 | |
| 2025-09-30 | $96.21M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $103.33M 10-Q · filed 2026-07-31 | |
| 2025-03-31 | $109.29M 10-Q · filed 2026-07-31 | |
| 2024-12-31 | $91.99M 10-Q · filed 2026-07-31 | |
| 2024-09-30 | $97.22M 10-Q · filed 2025-11-12 | $97.22M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $8.88M 10-Q · filed 2025-11-12 | $8.88M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $12.43M 10-Q · filed 2025-11-12 | $12.43M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $8.10M 10-K · filed 2026-03-10 | $8.10M 10-K · filed 2024-03-28 |
| 2023-09-30 | $11.29M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $13.22M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $14.28M 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $1.49M 10-K · filed 2025-03-25 | $1.49M 10-K · filed 2023-03-31 |
| 2022-09-30 | $3.95M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $6.78M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $1.61M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $4.24M 10-K · filed 2024-03-28 | |
| 2021-09-30 | $7.24M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $1.47M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $3.10M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $4.63M 10-K · filed 2023-03-31 | |
| 2020-09-30 | $7.40M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $3.03M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $3.42M 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $3.77M 10-K · filed 2022-03-29 | |
| 2019-09-30 | $6.54M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $8.62M 10-Q · filed 2019-11-14 | |
| 2019-03-31 | $10.34M 10-Q · filed 2019-11-14 | |
| 2018-12-31 | $11.77M 10-K/A · filed 2021-04-16 | |
| 2018-09-30 | $4.92M 10-Q · filed 2019-11-14 | $4.94M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $6.22M 10-Q · filed 2019-11-14 | $6.23M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $7.99M 10-Q · filed 2019-11-14 | $8.00M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $8.88M 10-K · filed 2020-03-30 | |
| 2017-09-30 | $10.16M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $11.27M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $14.11M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $17.14M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $46.69M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $50.89M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $55.33M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $60.42M 10-K · filed 2018-04-02 | |
| 2015-10-31 | $63.93M 10-Q · filed 2015-12-10 | |
| 2015-07-31 | $67.37M 10-Q · filed 2015-09-09 | |
| 2015-04-30 | $70.43M 10-K · filed 2017-03-16 | |
| 2015-01-31 | $75.36M 10-Q · filed 2015-03-17 | |
| 2014-10-31 | $77.59M 10-Q · filed 2014-12-15 | |
| 2014-07-31 | $81.54M 10-Q · filed 2014-09-15 | |
| 2014-04-30 | $82.86M 10-K · filed 2017-03-16 | $82.89M 10-K · filed 2014-07-29 |
| 2014-01-31 | $30.30M 10-Q · filed 2014-03-17 | |
| 2013-10-31 | $2.85M 10-Q · filed 2013-12-17 | |
| 2013-07-31 | $1.13M 10-Q · filed 2013-09-17 | |
| 2013-04-30 | -$1.78M 10-K · filed 2017-03-16 | |
| 2013-01-31 | -$1.60M 10-Q · filed 2013-03-18 | |
| 2012-10-31 | -$58.03K 10-Q · filed 2012-12-14 | |
| 2012-07-31 | -$638.30K 10-Q · filed 2012-09-19 | |
| 2012-04-30 | -$346.05K 10-K · filed 2014-07-29 | |
| 2012-01-31 | -$871.46K 10-Q · filed 2012-03-15 | |
| 2011-10-31 | -$3.73M 10-Q · filed 2011-12-15 | |
| 2011-07-31 | -$1.62M 10-Q · filed 2011-09-19 | |
| 2011-04-30 | -$3.72M 10-K · filed 2013-06-26 | |
| 2010-04-30 | $2.13M 10-K · filed 2012-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |